SAN FRANCISCO, February 15, 2016 /PRNewswire/ --
The global retinal implant market for is expected to reach over USD 1,117 million by 2022, according to a new report by Grand View Research, Inc. Some key drivers of the bionic eye market include rising burden of blindness with increasing aging population and successful completion of clinical trials resulting in entry of breakthrough technologies in the market.
(Logo: http://photos.prnewswire.com/prnh/20150105/723757)
Growing age is one of the prime factors resulting in expansion of visually impaired patients in the world. According to the World Health Organization (WHO), around 65% of the total visually impaired population globally (i.e., approximately 285 million) is aged 50 or more.
Additionally, the visually impaired population aged above 50 years accounts for 20% of the global population. Age-related Macular Degeneration (AMD) and Retinitis Pigmentosa (RP) are the most common causes of blindness. According to the WHO, AMD is the third leading cause of visual impairment with a prevalence rate of 8.7%. Considering growth of target population, demand for retinal prosthetics is anticipated to rise swiftly during the forecast period.
Browse full research report with TOC on "Retinal Implant Market Analysis by Device Type (Argus II, Implantable Telescope, Alpha IMS) And Segment Forecasts To 2022" at: http://www.grandviewresearch.com/industry-analysis/retinal-implant-market
Moreover, alternative therapies such as anti-angiogenic drugs, laser therapy, Photodynamic Laser Therapy (PTD), and vitamins fail to completely cure AMD and RP. These treatments delay the vision loss with slowing progression of the disease. However, devices such as Argus II and miniature telescope are capable of restoring the vision in blind patients. As a result, adoption of retinal implants is escalating with rising awareness about the availability of the product in the market.
On the other hand, high cost of commercially available products and stringent regulatory guidelines are primarily impeding growth of the global Retinal Implant Market. Furthermore, requirements of skilled professionals to perform implant surgery, and thereby necessity of training healthcare staff is further challenging adoption of bionic eye in the market.
Further key findings from the report suggest:
Grand View Research has segmented the Retinal Implant Market on the basis of device type and region:
Browse related reports by Grand View Research:
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Read Our Blogs - grandviewresearchinc.blogspot.com, esorics2010.org/
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email:sales@grandviewresearch.com
Web: http://www.grandviewresearch.com
Share this article